Q/C Technologies, Inc. Inventory Write-down
Q/C Technologies, Inc. (QCLS) reported Inventory Write-down of $3.83 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2021-03-01
- Q/C Technologies, Inc. inventory write-down for the quarter ending 2020-03-31 was $3.83K.
- Q/C Technologies, Inc. inventory write-down for the quarter ending 2019-12-31 was $245.57K, a 307.73% increase year-over-year.
- Q/C Technologies, Inc. inventory write-down for the quarter ending 2019-09-30 was $79.41K, a 63.85% decline year-over-year.
- Q/C Technologies, Inc. inventory write-down for the quarter ending 2019-06-30 was $41.85K, a 459.70% increase year-over-year.
- Q/C Technologies, Inc. inventory write-down for fiscal 2019 was $372.00K, a 33.32% increase from fiscal 2018.
- Q/C Technologies, Inc. inventory write-down for fiscal 2018 was $279.03K, a 76.91% decline from fiscal 2017.
- Q/C Technologies, Inc. inventory write-down for fiscal 2017 was $1.21M, a 3637.74% increase from fiscal 2016.
- Q/C Technologies, Inc. inventory write-down for fiscal 2016 was $32.33K.
| Period end | Inventory Write-down 3 month | Inventory Write-down 3 month as first filed | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 9 month as first filed | Inventory Write-down 12 month | Inventory Write-down 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-03-31 | $3.83K 10-Q · filed 2020-05-15 | $249.41K derived: sum of 2 quarters · filed 2021-03-01 | $328.82K derived: sum of 3 quarters · filed 2021-03-01 | $370.67K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-12-31 | $245.57K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $324.99K derived: sum of 2 quarters · filed 2021-03-01 | $366.84K derived: sum of 3 quarters · filed 2021-03-01 | $372.00K 10-K · filed 2021-03-01 | |||
| 2019-09-30 | $79.41K 10-Q · filed 2020-11-16 | $121.26K derived: sum of 2 quarters · filed 2020-11-16 | $126.42K 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $41.85K 10-Q · filed 2019-08-14 | ||||||
| 2018-12-31 | $60.23K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $279.93K derived: sum of 2 quarters · filed 2020-03-25 | $287.41K derived: sum of 3 quarters · filed 2020-03-25 | $279.03K 10-K · filed 2020-03-25 | $453.76K 10-K · filed 2019-04-01 | ||
| 2018-09-30 | $219.70K 10-Q · filed 2018-11-14 | $227.18K derived: sum of 2 quarters · filed 2019-08-14 | $218.80K 10-Q · filed 2019-11-14 | $251.98K 10-Q · filed 2018-11-14 | $1.46M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-06-30 | $7.48K 10-Q · filed 2019-08-14 | $7.82K 10-Q · filed 2018-08-14 | $32.28K 10-Q · filed 2019-08-14 | $1.24M derived: sum of 3 quarters · filed 2019-08-14 | $1.24M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $24.46K 10-Q · filed 2019-05-20 | $1.23M derived: sum of 2 quarters · filed 2019-05-20 | $1.23M derived: sum of 3 quarters · filed 2019-05-20 | $1.25M derived: sum of 4 quarters · filed 2019-05-20 | |||
| 2017-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.21M derived: sum of 2 quarters · filed 2019-04-01 | $1.23M derived: sum of 3 quarters · filed 2019-04-01 | $1.21M 10-K · filed 2019-04-01 | $26.12K 10-K · filed 2018-04-03 | ||
| 2017-09-30 | $2.66K 10-Q · filed 2018-11-14 | $24.21K derived: sum of 2 quarters · filed 2018-11-14 | $3.16K 10-Q · filed 2018-11-14 | $60.94K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $21.54K 10-Q · filed 2018-08-14 | $21.54K 10-Q · filed 2018-08-14 | $58.27K derived: sum of 3 quarters · filed 2018-08-14 | $83.24K derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $32.33K 10-Q · filed 2018-07-13 | $36.73K derived: sum of 2 quarters · filed 2018-07-13 | $61.70K derived: sum of 3 quarters · filed 2018-07-13 | $61.70K derived: sum of 4 quarters · filed 2018-07-13 | |||
| 2016-12-31 | $4.40K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-07-13 | $29.36K derived: sum of 2 quarters · filed 2018-07-13 | $29.36K derived: sum of 3 quarters · filed 2018-07-13 | $32.33K 10-K/A · filed 2018-07-13 | |||
| 2016-09-30 | $24.96K 10-Q/A · filed 2018-07-13 | $24.96K derived: sum of 2 quarters · filed 2018-07-13 | $27.93K 10-Q/A · filed 2018-07-13 | ||||
| 2016-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-07-13 | $2.97K 10-Q/A · filed 2018-07-13 | |||||
| 2016-03-31 | $2.97K 10-Q · filed 2017-05-15 | ||||||
| 2015-09-30 | $252.00 10-Q · filed 2016-11-14 | $252.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |